TI
CEROW

Telemetry Investments’s CERo Therapeutics Warrants CEROW Stock Holding History

Telemetry Investments’s Portfolio CEROW Stock Details CEROW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$5K Hold
125,114
– – 0.01% 122
2022
Q3 		$18K Hold
125,114
– – 0.02% 132
2022
Q2 		$13K Buy
125,114
+3,500
+3% +$564 0.02% 144
2022
Q1 		$23K Buy
121,614
+106,297
+694% +$39.5K 0.04% 139
2021
Q4 		$7K Buy
+15,317
New +$7.06K 0.01% 177

Other funds holding CEROW

MP
Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return
RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.32B AUM 1.82% 1-Year Est. Return
SCM
Segantii Capital Management Hong Kong $1.54B AUM 16.73% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $1.14B AUM 6.91% 1-Year Est. Return
HCM
Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.18B AUM 50.44% 1-Year Est. Return
CF
Cantor Fitzgerald New York $9.31B AUM 73.66% 1-Year Est. Return
SCM
Shaolin Capital Management Miami, Florida $2.1B AUM 64.05% 1-Year Est. Return
CS
Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $6.07B AUM 34.81% 1-Year Est. Return

Telemetry Investments's CEROW Position: Q4 2022 in Review

Telemetry Investments held its CERo Therapeutics Warrants (CEROW) position steady in Q4 2022 at 125,114 shares worth $5K. The position accounts for 0.01% of the portfolio, ranked #122.

Telemetry Investments first reported a position in CEROW in Q4 2021 and has held it in 5 quarters since. The position peaked at $23K in Q1 2022. 49 funds tracked by Wall St. Rank hold CEROW as of Q4 2022.

  • Telemetry Investments held 125,114 shares of CERo Therapeutics Warrants worth $5K as of Q4 2022.
  • Telemetry Investments left its CERo Therapeutics Warrants share count unchanged in Q4 2022.
  • CERo Therapeutics Warrants made up 0.01% of Telemetry Investments's portfolio in Q4 2022, its #122 holding.
  • Telemetry Investments first reported a position in CERo Therapeutics Warrants in Q4 2021 and has held it in 5 quarters since.
  • Telemetry Investments's CERo Therapeutics Warrants position peaked at $23K in Q1 2022.
  • 49 funds tracked by Wall St. Rank held CERo Therapeutics Warrants as of Q4 2022.

Based on Telemetry Investments's 13F filing for Q4 2022, filed 14 Feb 2023.